| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |